skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 780  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Visual Acuity remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective
Material Type:
Article
Add to My Research

The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective

PloS one, 2018-05, Vol.13 (5), p.e0197670-e0197670 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 van Asten et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 van Asten et al 2018 van Asten et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0197670 ;PMID: 29772018

Full text available

2
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
Material Type:
Article
Add to My Research

Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration

Cochrane database of systematic reviews, 2020-05, Vol.2020 (5), p.CD012208 [Peer Reviewed Journal]

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012208.pub2 ;PMID: 32374423

Full text available

3
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
Material Type:
Article
Add to My Research

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis

Cochrane database of systematic reviews, 2018-10, Vol.2018 (10), p.CD007419 [Peer Reviewed Journal]

Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD007419.pub6 ;PMID: 30325017

Full text available

4
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
Material Type:
Article
Add to My Research

Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration

Cochrane database of systematic reviews, 2019-03, Vol.2019 (3), p.CD005139 [Peer Reviewed Journal]

Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD005139.pub4 ;PMID: 30834517

Full text available

5
Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
Material Type:
Article
Add to My Research

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study

PloS one, 2020-01, Vol.15 (1), p.e0227557-e0227557 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Hamilton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Hamilton et al 2020 Hamilton et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0227557 ;PMID: 31961888

Full text available

6
Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study
Material Type:
Article
Add to My Research

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

PloS one, 2016-05, Vol.11 (5), p.e0153052-e0153052 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Schauwvlieghe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Schauwvlieghe et al 2016 Schauwvlieghe et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0153052 ;PMID: 27203434

Full text available

7
Advances in the treatment of diabetic retinopathy
Material Type:
Article
Add to My Research

Advances in the treatment of diabetic retinopathy

Journal of diabetes and its complications, 2019-12, Vol.33 (12), p.107417, Article 107417 [Peer Reviewed Journal]

2019 ;Copyright © 2019. Published by Elsevier Inc. ;Copyright Elsevier Limited Dec 2019 ;ISSN: 1056-8727 ;EISSN: 1873-460X ;DOI: 10.1016/j.jdiacomp.2019.107417 ;PMID: 31669065

Full text available

8
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
Material Type:
Article
Add to My Research

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

The Lancet (British edition), 2015-12, Vol.386 (10011), p.2395-2403 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 12, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)00345-1 ;PMID: 26431823 ;CODEN: LANCAO

Full text available

9
Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
Material Type:
Article
Add to My Research

Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study

PloS one, 2020-12, Vol.15 (12), p.e0244183 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Holz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Holz et al 2020 Holz et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0244183 ;PMID: 33378369

Full text available

10
A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration
Material Type:
Article
Add to My Research

A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration

British journal of ophthalmology, 2016-07, Vol.100 (7), p.914-917 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2015-306987 ;PMID: 26516125 ;CODEN: BJOPAL

Full text available

11
Aflibercept for neovascular age‐related macular degeneration
Material Type:
Article
Add to My Research

Aflibercept for neovascular age‐related macular degeneration

Cochrane database of systematic reviews, 2016-02, Vol.2016 (2), p.CD011346-CD011346 [Peer Reviewed Journal]

Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011346.pub2 ;PMID: 26857947

Full text available

12
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
Material Type:
Article
Add to My Research

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration

Scientific reports, 2017-08, Vol.7 (1), p.9196-8, Article 9196 [Peer Reviewed Journal]

2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-09632-0 ;PMID: 28835685

Full text available

13
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
Material Type:
Article
Add to My Research

A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema

Graefe's archive for clinical and experimental ophthalmology, 2017-03, Vol.255 (3), p.463-473 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;Graefe's Archive for Clinical and Experimental Ophthalmology is a copyright of Springer, 2017. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-016-3472-1 ;PMID: 27632215

Full text available

14
Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
Material Type:
Article
Add to My Research

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema

Cochrane database of systematic reviews, 2018-04, Vol.2018 (4), p.CD011599 [Peer Reviewed Journal]

Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011599.pub2 ;PMID: 29669176

Full text available

15
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
Material Type:
Article
Add to My Research

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

Advances in therapy, 2017-03, Vol.34 (3), p.703-712 [Peer Reviewed Journal]

The Author(s) 2017 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-017-0483-1

Digital Resources/Online E-Resources

16
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration
Material Type:
Article
Add to My Research

Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration

American journal of ophthalmology, 2020-10, Vol.218, p.225-241 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2020.05.029 ;PMID: 32565050

Full text available

17
Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration
Material Type:
Article
Add to My Research

Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration

British journal of ophthalmology, 2020-05, Vol.104 (5), p.684-690 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2019-314446 ;PMID: 31611234

Full text available

18
Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
Material Type:
Article
Add to My Research

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

Journal of ocular pharmacology and therapeutics, 2018-12, Vol.34 (10), p.700-709 [Peer Reviewed Journal]

David Callanan, et al. 2018; Published by Mary Ann Liebert, Inc. 2018 ;ISSN: 1080-7683 ;EISSN: 1557-7732 ;DOI: 10.1089/jop.2018.0062 ;PMID: 30412448

Full text available

19
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration
Material Type:
Article
Add to My Research

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Journal of translational medicine, 2023-02, Vol.21 (1), p.133-133, Article 133 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-023-03937-7 ;PMID: 36810060

Full text available

20
Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion
Material Type:
Article
Add to My Research

Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion

Scientific reports, 2021-10, Vol.11 (1), p.20475-20475, Article 20475 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-00094-z ;PMID: 34650099

Full text available

Results 1 - 20 of 780  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (742)

Refine My Results

Creation Date 

From To
  1. Before 2009  (22)
  2. 2009 To 2011  (72)
  3. 2012 To 2014  (115)
  4. 2015 To 2018  (260)
  5. After 2018  (312)
  6. More options open sub menu

Resource Type 

  1. Articles  (779)
  2. Books  (1)
  3. More options open sub menu

Language 

  1. English  (756)
  2. Japanese  (113)
  3. Spanish  (16)
  4. Portuguese  (10)
  5. French  (6)
  6. Chinese  (5)
  7. German  (3)
  8. Norwegian  (2)
  9. Turkish  (1)
  10. More options open sub menu

Searching Remote Databases, Please Wait